Anti-PGK1 antibody [EPR19057]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
5
(2 Reviews)
|
(29 Publications)
Rabbit Recombinant Monoclonal PGK1 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Human, Rat samples. Cited in 29 publications.
View Alternative Names
PGKA, MIG10, OK/SW-cl.110, PGK1, Phosphoglycerate kinase 1, Cell migration-inducing gene 10 protein, Primer recognition protein 2, PRP 2
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-PGK1 antibody [EPR19057] (AB199438)
Immunofluorescent analysis of 100% methanol-fixed Jurkat (human T cell leukemia cell line from peripheral blood) cells labeling PGK1 with ab199438 at 1/250 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic and weak nuclear staining in Jurkat cells. The nuclear counterstain is DAPI (blue).
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-PGK1 antibody [EPR19057] (AB199438)
Immunofluorescent analysis of 100% methanol-fixed HeLa (human epithelial cell line from cervix adenocarcinoma) cells labeling PGK1 with ab199438 at 1/250 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic and weak nuclear staining in HeLa cells. The nuclear counterstain is DAPI (blue).
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-PGK1 antibody [EPR19057] (AB199438)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling PGK1 with ab199438 at 1/150 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/500 dilution was used as the secondary antibody.
- WB
Supplier Data
Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-PGK1 antibody [EPR19057] (ab199438) at 1/2000 dilution
Lane 1:
Human fetal brain lysate at 10 µg
Lane 2:
Human fetal heart lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution
Predicted band size: 45 kDa
Observed band size: 45 kDa
false
Exposure time: 1s
- WB
Supplier Data
Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-PGK1 antibody [EPR19057] (ab199438) at 1/2000 dilution
Lane 1:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 20 µg
Lane 3:
Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 45 kDa
Observed band size: 45 kDa
false
Exposure time: 1s
- WB
Supplier Data
Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-PGK1 antibody [EPR19057] (ab199438) at 1/2000 dilution
Lane 1:
Mouse brain lysate at 10 µg
Lane 2:
Mouse heart lysate at 10 µg
Lane 3:
Mouse kidney lysate at 10 µg
Lane 4:
Rat brain lysate at 10 µg
Lane 5:
Rat heart lysate at 10 µg
Lane 6:
Rat kidney lysate at 10 µg
Lane 7:
C6 (Rat glial tumor cells) whole cell lysate
Lane 8:
RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) whole cell lysate
Lane 9:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate
Lane 10:
NIH/3T3 (Mouse embryo fibroblast cells) whole cell lysate
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 45 kDa
Observed band size: 45 kDa
false
Exposure time: 1s
- WB
Supplier Data
Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)
Blocking and Diluting Buffer : 5% NFDM /TBST Lanes 3 and 4 Exposure : 60 seconds
Lanes 1 - 2:
Western blot - Anti-PGK1 antibody [EPR19057] (ab199438) at 1/1000 dilution
Lanes 3 - 4:
Western blot - Anti-PGK1 + PGK2 antibody [EPR14908] (<a href='/en-us/products/primary-antibodies/pgk1-pgk2-antibody-epr14908-ab186742'>ab186742</a>) at 1/5000 dilution
Lanes 1 and 3:
PGK1 Human Recombinant Protein at 20 µg
Lanes 2 and 4:
PGK2 Human Recombinant Protein at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 45 kDa
false
Exposure time: 5s
- WB
CiteAb
Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)
PGK1 western blot using anti-PGK1 antibody [EPR19057] ab199438. Publication image and figure legend from Elkis, Y., Cohen, M., et al., 2017, Nat Commun, PubMed 29038547.
ab199438 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab199438 please see the product overview.
Development of the Fer/FerT kinase inhibitor-E260 by using a yeast-based HTS system. a Native Fer (pAES-Fer) and a mutated kinase inactive Fer (pAES-FerY715F) were expressed in yeast cells using the pAES expression vector. Protein lysates from transfected cells were subjected to WB analysis using anti-HA (for HA-tagged Fer), anti-Fer, anti-phosphotyrosine (p-tyr), and anti-actin antibodies. b Growth curve of yeast cells expressing either the empty pAES vector, native Fer, inactive Fer, and non-transformed yeast cells; n = 3,±SE. c Scheme of the HTS program. d The chemical structure the 0342 compound. e The chemical structure of the E260 compound. f Growth curve of yeast transformed with the different plasmids and treated with either DMSO, 2 µM E260, or 2 µM 0342. pAES-harboring cells treated with DMSO, mutant Fer treated with DMSO, native Fer-expressing cells treated with DMSO, native Fer-expressing cells treated with 0342, native Fer-expressing cells treated with E260. Untransformed yeast cells served as a negative control; n = 3, ±SE. g Histograms depicting the 600 nm OD readings of the yeast growth-curves (presented in f) after 40 h; n = 3, ±SE. h Protein lysates prepared from yeast expressing mutant Fer and treated with DMSO for 24 h (pAES-FerY715F), active Fer and treated with 2 µM E260 (pAES-Fer E260), active Fer and treated with DMSO (pAES-Fer DMSO), or harboring the pAES vector alone and treated with DMSO, were subjected to WB analysis using anti-Fer, anti-p-tyr, and anti-PGK antibodies. Arrow on the right depicts the MW of Fer. This image presents one experiment representative of three, which gave similar results
false
Related conjugates and formulations (2)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-PGK1 antibody [EPR19057]
-
Anti-PGK1 antibody [EPR19057] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The PGK1 protein plays an essential role in energy production by participating in the glycolytic pathway. This enzyme functions independently and is not part of any complex. By converting 13-bisphosphoglycerate to 3-phosphoglycerate it supports cellular processes that require ATP. Such activity facilitates the high energy needs of cells ensuring proper cellular function and homeostasis.
Pathways
The enzyme PGK1 operates predominantly within the glycolytic and gluconeogenesis pathways. Throughout glycolysis it partners with enzymes like phosphofructokinase and pyruvate kinase facilitating the breakdown of glucose into pyruvate while generating ATP. In gluconeogenesis PGK1 aids in glucose formation which helps balance energy dynamics particularly in tissues like the liver and kidney.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (29)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:4393 PubMed39910105
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:65 PubMed39900910
2025
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 10:25 PubMed39837814
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 15:e70118 PubMed39731281
2024
Applications
Unspecified application
Species
Unspecified reactive species
Hematological oncology 42:e3316 PubMed39526588
2024
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 10:eadn6016 PubMed39167658
2024
Applications
Unspecified application
Species
Unspecified reactive species
Drug development research 85:e22223 PubMed38879780
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 25:2365449 PubMed38865161
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomaterials research 28:0035 PubMed38840655
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:109735 PubMed38706843
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com